Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Gilead Sciences (NASDAQ:GILD) Downgraded by Wall Street Zen to Buy
Best Medical Stocks To Keep An Eye On - January 23rd - Markets Daily
MOKAN Wealth Management Inc. Trims Position in Gilead Sciences, Inc. $GILD
Strs Ohio Purchases 24,284 Shares of Gilead Sciences, Inc. $GILD
Rakuten Investment Management Inc. Purchases New Shares in Gilead Sciences, Inc. $GILD - Markets Daily
Top Pharmaceutical Stocks To Watch Now - January 23rd - Daily Political
Grandfield & Dodd LLC Sells 20,655 Shares of Gilead Sciences, Inc. $GILD
Vest Financial LLC Acquires 6,019 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
GILD: Extended HIV Franchise Strength Will Support Stronger Long-Term Earnings Power
CapWealth Advisors LLC Lowers Position in Gilead Sciences, Inc. $GILD
Gilead Sciences (NASDAQ:GILD) Director Jeffrey Bluestone Sells 5,000 Shares - Stock Observer
Analysts Conflicted on These Healthcare Names: Insulet (PODD) and Gilead Sciences (GILD) | Markets Insider
Jeffrey Bluestone Sells 5,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock
Gilead Sciences (NASDAQ:GILD) Reaches New 12-Month High After Analyst Upgrade - Markets Daily
Rothschild & Co Redburn Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price
Gilead Sciences (GILD) Valuation Check After Recent Share Price Softness
Gilead's Yeztugo Approval Highlights HIV Growth And Acquisition-Fueled Upside
Bernstein Remains a Buy on Gilead Sciences (GILD) | Markets Insider
Gilead Sciences, Inc. $GILD Shares Acquired by Wealth Enhancement Advisory Services LLC
Royal Bank Of Canada Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock
Triasima Portfolio Management inc. Grows Position in Gilead Sciences, Inc. $GILD - Daily Political
Tradewinds LLC. Takes $507,000 Position in Gilead Sciences, Inc. $GILD - Markets Daily
Gilead Sciences, Inc. (NASDAQ:GILD) Given Average Rating of "Moderate Buy" by Brokerages
Tradewinds LLC. Purchases New Position in Gilead Sciences, Inc. $GILD - Stock Observer
Allstate Corp Grows Position in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Sold by QRG Capital Management Inc.
Andrew Dickinson Sells 3,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock
Ritholtz Wealth Management Increases Stock Position in Gilead Sciences, Inc. $GILD - Markets Daily
Gilead Sciences, Inc. $GILD Shares Purchased by Ritholtz Wealth Management - Stock Observer
Morgan Stanley Cuts Gilead Sciences (NASDAQ:GILD) Price Target to $150.00 - Daily Political
Gilead Sciences, Inc. $GILD Shares Sold by Conning Inc.
Has Gilead Sciences (GILD) Moved Too Far After Strong Multi‑Year Share Price Gains
A Look At Gilead Sciences (GILD) Valuation After JP Morgan Conference HIV Pipeline Update
Morgan Stanley Issues Pessimistic Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price
Gilead Sciences, Inc. $GILD Shares Acquired by TD Private Client Wealth LLC
Liberty One Investment Management LLC Increases Stake in Gilead Sciences, Inc. $GILD
Polaris Capital Management LLC Sells 12,500 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Acquired by PKO Investment Management Joint Stock Co
Analysts Offer Insights on Healthcare Companies: Biodesix (BDSX), Gilead Sciences (GILD) and Agios Pharma (AGIO) | Markets Insider
Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial
Meeder Asset Management Inc. Has $16.76 Million Position in Gilead Sciences, Inc. $GILD - Markets Daily
Sumitomo Mitsui Trust Group Inc. Buys 27,232 Shares of Gilead Sciences, Inc. $GILD
Nexus Investment Management ULC Buys 21,220 Shares of Gilead Sciences, Inc. $GILD
9,809 Shares in Gilead Sciences, Inc. $GILD Bought by Elite Wealth Management Inc.
UBS and Citi Go Bullish on Gilead Sciences (GILD)
Meeder Asset Management Inc. Has $16.76 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Stock Observer
Sumitomo Mitsui Trust Group Inc. Has $369.58 Million Stock Position in Gilead Sciences, Inc. $GILD - Stock Observer
Nexus Investment Management ULC Increases Position in Gilead Sciences, Inc. $GILD - Daily Political
Tema Etfs LLC Buys 25,912 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Is Gilead Sciences (GILD) Pricing Reflecting Recent 38.5% One Year Share Return?
HB Wealth Management LLC Buys 13,249 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences (NASDAQ:GILD) Research Coverage Started at UBS Group - Markets Daily
Oregon Public Employees Retirement Fund Acquires 34,235 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences, Inc. $GILD Position Lessened by Capital Investment Advisors LLC
11 Most Undervalued Blue Chip Stocks to Buy Now
Hennion & Walsh Asset Management Inc. Increases Position in Gilead Sciences, Inc. $GILD - Daily Political
Patient advocates urge U.S. court to halt AFP prescription operations
GILD: HIV PrEP Strength And Oncology Mixed Results Will Shape Outlook
What Gilead Sciences (GILD)'s OncoNano Drug-Encapsulation Deal Means For Shareholders
Citigroup Boosts Gilead Sciences (NASDAQ:GILD) Price Target to $140.00 - Daily Political
Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Momentum
Gilead Sciences (NASDAQ:GILD) Given Buy Rating at UBS Group - Daily Political
Securian Asset Management Inc. Sells 5,084 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Assessing Gilead Sciences (GILD) Valuation After Mixed Near Term Returns And 9.4% Undervaluation Estimate
11,480 Shares in Gilead Sciences, Inc. $GILD Bought by TriaGen Wealth Management LLC
Wall Street Zen Upgrades Gilead Sciences (NASDAQ:GILD) to "Strong-Buy" - Zolmax
Gateway Investment Advisers LLC Raises Stock Position in Gilead Sciences, Inc. $GILD
SteelPeak Wealth LLC Sells 94,279 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Purchased by Asset Management One Co. Ltd.
Gilead Sciences, Inc. $GILD Stock Position Lifted by Allspring Global Investments Holdings LLC
Gilead Sciences, Inc. $GILD is Verity & Verity LLC's 10th Largest Position - Daily Political
Gilead Sciences (NASDAQ:GILD) Upgraded to "Strong-Buy" at Wall Street Zen
Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial
Bank Pictet & Cie Europe AG Boosts Holdings in Gilead Sciences, Inc. $GILD
Gilead Sciences Q3 EPS Forecast Raised by Zacks Research
Morgan Stanley Expects Gilead Sciences (GILD) to Thrive as Biopharma Policy Uncertainties Fade in 2026
Lee Johnson Capital Management LLC Makes New Investment in Gilead Sciences, Inc. $GILD
Ascent Group LLC Buys 11,926 Shares of Gilead Sciences, Inc. $GILD
Gilead (GILD) Reaches Pricing Agreement with US Government to Lower Drug Costs
Daniel Patrick O'day Sells 10,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock
Google's Marc Berson appointed to Mastek Inc's Board of Directors
Diversified Trust Co Increases Holdings in Gilead Sciences, Inc. $GILD
Abacus FCF Advisors LLC Reduces Holdings in Gilead Sciences, Inc. $GILD
Is Gilead Sciences (GILD) An Affordable Healthcare Stocks to Invest In?
14 Best Pharma Dividend Stocks to Buy in 2026
Long-Term Stock Portfolio: 10 Best Stocks for the Next Decade
Sapient Capital LLC Sells 8,077 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Bought by E. Ohman J or Asset Management AB
Meyer Handelman Co. Has $38.56 Million Stock Holdings in Gilead Sciences, Inc. $GILD
Highland Capital Management LLC Invests $1.76 Million in Gilead Sciences, Inc. $GILD
